Blog
Santosh Kesari, MD, PhD, Named Regional Medical Director for the Research Clinical Institute, Providence Southern California
by Guest Author
By Rex Hoffman, MD, Chief Medical Officer, SoCal Clinical Institutes and Chief Medical Officer, Providence Holy Cross Medical Center April 1, 2021 – I am pleased to announce that Santosh Kesari, MD, PhD, has been named regional medical director of Southern California’s Research Clinical Institute....
Multiple Sclerosis and COVID-19 Vaccines
by Barbara Giesser
March is National Multiple Sclerosis Awareness month. When the COVID-19 pandemic first emerged, there were many questions about how persons with Multiple Sclerosis (MS) would be affected. Now a year later, we have answers to some of those questions, and other issues that have yet...
Pacific Neuroscience Institute Launches New Psychedelic-Assisted Clinical Trial
by Zara Jethani
The Visual Healing® study at PNI tests a nature-themed immersive video experience in psilocybin-assisted therapy for patients with alcohol use disorder.
Treating the Effects of Cancer on Mind and Spirit | Dr. Shanthi Gowrinathan
by Anthony Effinger
Cancer takes a toll on the mind, too, no matter what organ system it affects. Dr. Shanthi Gowrinathan has seen all of these things. She’s the Director of Psycho-Oncology at PNI, and she specializes in the mental health of cancer patients.
Stop & Smell the Roses: Experiencing a Brain Aneurysm
by Guest Author
A South Bay man survives a life-threatening brain aneurysm thanks to a rapid medical response at Providence Little Company Medical Center in Torrance, California. Charles Demachy, a local SoCal plant nursery owner, remembers the headache most of all. It was crushing and “weird,” he says....
PNI’s 2020 Year-in-Review & What To Expect in 2021
by Zara Jethani
PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved. We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...
ONCOLOGY Clinical Trials Round-Up: March 2021
by Mini Gill
New Studies EpicentRx Beta-Prime: A Phase I, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects with Refractory Solid Tumors (NCT04673942) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade...
Turning Pain into Progress
by Guest Author
Meet Sheena Reddy: A woman honors her mother’s fight against glioblastoma cancer while helping others.
New Hope on Vanquishing Glioblastoma | Dr. Santosh Kesari
by Anthony Effinger
Listen to our conversation with Dr. Kesari to find out what GBM treatments make him believe that big breakthroughs are on the horizon for treating this tricky, and tragic, disease.
What is Multiple Sclerosis?
by Barbara Giesser
Multiple Sclerosis occurs unexpectedly, usually when people are just embarking on their adult lives. MS is believed to be an autoimmune disease. Normally, the immune system recognizes the body as “Self’ and protects it from outside entities, such as germs. The central nervous system or...
Last updated: March 3rd, 2023